PDF가 표시되지 않으면 여기를 클릭하여 다운로드

1
고경석, 허재준, 오재민 (2021). “스마트팩토리 도입에 영향을 미치는 요인에 관한 연구 - 고객사와 공급사 간 비교를 중심으로 -,” 경영학연구, 제25권 3호, pp.129-151. (Ko, K. S, Huh, J. J. and Oh, J. I. (2021). “A Study on the Factors that Affect the Adoption of a Smart Factory - Focusing on the Comparison between Customers and Suppliers,” Korea Business Review, 25(3), pp.129-151.) Google Scholar ›
2
김동숙, 송인명, 최상은, 박은자, 이주연, 허규남, 신주영, 이혜성 (2024). “의약품 유통 선진화를 위한 유통 체계 개선방안 연구,” 건강보험심사평가원. https://www.hira.or.kr/ra/trend/study/getReportInfo.do?pgmid=HIRAA030095000000&study DataSeq=707&brd ScnBltNo=4&brd BltNo= (Kim, D. S., Song, I. M., Choi, S., Park, E., Lee, J., Heo, G., Shin, J. and Lee, H. (2024). “A Study on the Efficiency of High-Growth ICT Service Companies,” Health Insurance Review & Assessment Service) Google Scholar ›
3
권오탁 (2018). “품질관리가 필요한 의료장비 선정기준 및 우선 적용대상 의료장비 선정,” 건강보험심사평가원 정책동향, 제12권 3호, pp.33-48. (Kwon, O. K. (2018). “Election Criteria for Medical Equipment Requiring Quality Control and Selection of Medical Equipment Subject to Priority Application,” Health Insurance Review & Assessment Service Policy Trends, 12(3), pp.33-48.) Google Scholar ›
4
데일리팜 (2025). “원료약 자급도 2년새 12% → 31%...국내 생산 원료 사용” https://www.dailypharm.com/Users/News/News View.html?ID=324429, 2025년 8월 접속. (Dailypharm (2025). “Self-sufficiency rate for raw pharmaceutical materials jumps from 12% to 31% in two years...Domestically produced raw materials used” https://www.dailypharm.com/Users/News/News View.html?ID=324429, retrieved August 2025) Google Scholar ›
5
박민규, 김민용, 양성병 (2020). “계층화분석기법(AHP)을 이용한 건강보험 부당청구 감지지표 우선순위 도출,” 경영학연구, 제24권 1호, pp.89-105. (Park, M. K., Kim, M. Y. and Yang, S. B. (2020). “Prioritizing Indicators for Detecting Fraudulent Claims of Health Insurance Based on AHP),” Korea Business Review, 24(1), pp.89-105.) Google Scholar ›
6
박은자, 박주현, 박나영, 곽윤경, 천희란, 오영호 (2023). “코로나19 대유행에 따른 국민의 건강영향과 의료이용 변화 분석,” 한국보건사회연구원, 연구보고서 2023-20, https://doi.org/10.23060/KIHASA.A.2023.20 (Park, E., Park, J., Park, N. Y., Kwak, Y. K., Chun, H. and Oh, Y. (2023). “Analysis of Changes in Health Behavior, Health Status and Medical Use During COVID-19 Pandemic,” Korea Institute for Health and Social Affairs, Research Report 2023-20, https://doi.org/10.23060/KIHASA.A.2023.20) Google Scholar ›
7
이충배, 류희찬 (2020). “코로나-19 확산 하에서 공급사슬 위험관리전략에 관한 연구,” 통상정보연구, 제22권 4호, pp.137-157. (Lee, C. B. and Ryu, H. C. (2020). “A Study on Supply Chain Risk Management Strategies During Covid-19,” International Commerce and Information Review, 22(4), pp.137-157.) Google Scholar ›
8
지성우, 하헌구 (2022). “의약품 콜드체인 물류서비스 품질에 근거한 물류서비스 협력사 결정요인 분석: AHP (Analytic Hierarchy Process)의 적용,” 로지스틱스연구, 제30권 2호, pp.1-19. (Ji, S. W. and Ha, H. K. (2022). “Analysis of Determinants of Pharmaceutical Cold Chain Logistics Service Quality: Application of AHP(Analytic Hierarchy Process),” Korea Logistics Academy, 30(2), pp.1-19.) Google Scholar ›
9
정지은, 최윤희, 허선경 (2022). “바이오의약품산업의 가치사슬별 경쟁력 진단과 정책 방향,” 월간 KIET 산업경제, 제287권, pp.48-60. (Jeong, J., Choi, Y. and Heo, S. (2022). “Competitiveness Diagnosis and Policy Direction by Value Chain of the Biopharmaceutical Industry,” Monthly KIET Industrial Economy, 287, pp.48-60.) Google Scholar ›
10
정지훈, 고영희 (2023). “국내 바이오제약 기업 성장 프로세스와 코로나-19 기회활용 전략: 셀트리온과 삼성바이오로직스 전략 메커니즘 비교분석,” 경영학연구, 제27권 1호, pp.27-52. (Jeong, J. and Ko, Y. H. (2023). “Growth Process of Domestic Biopharmaceutical Companies and Strategies for Utilizing COVID-19 Opportunities,” Korea Business Review, 27(1), pp.27-52.) Google Scholar ›
11
정희범, 정의범, 이돈희 (2024). “헬스케어 공급망 리스크 주요 이슈 분석: 뉴스기사를 중심으로,” 한국생산관리학회지, 제35권 3호, pp.355-379. (Jung, H. B., Jeong, E. B. and Lee, D. H. (2024). “Analysis of Key Risk Issues in Healthcare Supply Chains: Focusing on News Media Publications,” Korean Production and Operations Management Society, 35(3), pp.355-379.) Google Scholar ›
12
최병돈, 이돈희 (2013). “AHP 기법을 이용한 의료 SCM 성공요인에 대한 비교: 자체운영 vs. 아웃소싱,” 서비스경영학회지, 제14권 5호, pp.125-146. (Choe, B. D. and Lee, D. H. (2013). “A comparative study on the critical success factors of healthcare SCM using the AHP method: in-house vs. outsourcing operations in healthcare organizations,” Journal of Korean Service Management Society, 14(5), pp.125-146.) Google Scholar ›
13
이창효 (1999). 집단의사결정론, 서울: 세종출판사. (Lee, C. H. (1999). Group Decision Theory, Sejong Publishing, Seoul) Google Scholar ›
14
Ahmad, F., Shamayleh, A., Daghfous, A., Al Khatib, I., Al Salloum, G., and Elabed, S. (2024). “Healthcare Supply Chain Disruption Risks,” Operations and Supply Chain Management: An International Journal, 17(2), pp.264-283. Google Scholar ›
15
Ahmadi, E., Mosadegh, H., Maihami, R., Ghalehkhondabi, I., Sun, M., and Suer, G. A. (2022). “Intelligent inventory management approaches for perishable pharmaceutical products in a healthcare supply chain,” Computers and Operations Research, 147, 105968. Google Scholar ›
16
Anozie, U. C., Adewumi, G., Obafunsho, O., Toromade, A., and Olaluwoye, O. (2024). “Leveraging advanced technologies in supply chain risk management (SCRM) to mitigate healthcare disruptions: A comprehensive review,” World Journal of Advanced Research and Reviews, 23(1), pp.1039-1045. Google Scholar ›
17
Benazzouz, T., Charkaoui, A., and Echchatbi, A. (2018). “Risks related to the medical supply chain in public hospitals in Morocco: Qualitative study,” Pharmacien Hospitalier et Clinicien, 54(1), pp.19-29. Google Scholar ›
18
Breen, L. (2008). “A Preliminary Examination of Risk in the Pharmaceutical Supply Chain (PSC) in the National Health Service (NHS),” Journal of Service Science and Management, 1, pp.193-199. Google Scholar ›
19
Čerkauskienė, A., and Meidute-Kavaliauskiene, I. (2023). “The aspects of supply chain risk management in the healthcare industry,” Journal of Logistics, Informatics and Service Science, 10(1), pp.1-19. Google Scholar ›
20
Chan, C., and Green, L. (2013). “Improving access to healthcare: models of adaptive behavior,” in Brian, T. (ed.), Handbook of Healthcare Operations Management, Springer, New York. http://dx.doi.org/10.1007/978-1-4614-5885-2. Google Scholar ›
21
Chapman, P., Christopher, M., and Wilding, R. (2002). “Identifying and managing supply chain vulnerability,” Journal of the Institute of Logistics and Transport, 4(4), pp.59-64. Google Scholar ›
22
CIDRAP (2022). “RDSP maps medicine supply to US to predict, prevent shortages (part 2 of 2),” Center for Infectious Disease Research and Policy. https://www.cidrap.umn.edu/covid-19/rdsp-maps-medicine-supply-us-predict-prevent-shortages-part-2-2. Google Scholar ›
23
Dogbe, C. S. K., Iddris, F., Duah, E., Boateng, P. A., and Kparl, E. M. (2023). “Analyzing the health supply chain risks during COVID-19 pandemic: The moderating role of risk management,” Cogent Business & Management, 10(3). https://doi.org/10.1080/23311975.2023.2281716 Google Scholar ›
24
Elleuch, H., Hachicha, W., and Chabchoub, H. (2014). “A combined approach for supply chain risk management: description and application to a real hospital pharmaceutical case study,” Journal of Risk Research, 17(5), pp.641-663. Google Scholar ›
25
Getele, G. K., and Ruoliu, X. (2023). “Service supply chain risk management in the public healthcare sector,” International Journal of Emerging Markets, 19(11), pp.4259-4285. Google Scholar ›
26
Globe Newswire (2024). “Healthcare Market Size Worth US$ 44,760.73 Billion By 2032, Continuous Advancements in Biotechnology & Pharmaceuticals Propels Growth,” Research by SNS Insider. https://www.globenewswire.com/news-release/2024/08/01/2923001/0/en/Healthcare-Market-Size-Worth-US-44-760-73-Billion-By-2032-Continuous-Advancements-in-Biotechnology-Pharmaceuticals-Propels-Growth-Research-by-SNS-Insider.html. Google Scholar ›
27
Guo, Y., Liu, F., Song, J., and Wang, S. (2025). “Supply chain resilience: A review from the inventory management perspective,” Fundamental Research, 5(2), pp.450-463. Google Scholar ›
28
Jaberidoost, M., Nikfar, S., Abdollahiasl, A., and Dinarvand, R. (2013). “Pharmaceutical supply chain risks: a systematic review,” DARU Journal of Pharmaceutical Sciences, 21(1), 69(pp.1-7). Google Scholar ›
29
Jeong, E., and Lee, D. (2025). “Metaverse applications in healthcare: opportunities and challenges,” Service Business, 19(1), 4(pp.1-38). Google Scholar ›
30
Market Research (2025). “Healthcare Supply Chain Management,” Global Industry Analysts. https://www.marketresearch.com. Google Scholar ›
31
Mustaffa, N. H., and Potter, A. (2009), Healthcare supply chain management in Malaysia: a case study [Doctoral dissertation, Cardiff University, UK] Google Scholar ›
32
Nze-Ekpebie, R., and Udealor, L. (2023). “Global Supply Chain Effects on Medical Devices,” SSRN, https://ssrn.com/abstract=4477682. Google Scholar ›
33
OECD (2024). “Securing Medical Supply Chains in a Post-Pandemic World,” OECD Health Policy Studies, OECD Publishing, Paris. https://doi.org/10.1787/119c59d9-en. Google Scholar ›
34
Owens & Minor (2023). “Operating Room Efficiency - 2023 Research Report,” Owens & Minor, pp.1-21. Google Scholar ›
35
Ramesh, N., and Dickerson, T. (2022). “Just-in-Time to Just-in-Case,” IEEE Engineering Management Review, 50(2), pp.17-18. Google Scholar ›
36
Saaty, T. L. (1983). “Priority Setting in Complex Problem,” IEEE Transactions on Engineering Management, 30(3), pp.140-155. Google Scholar ›
37
Saaty, T. (1995). “Transport planning with multiple criteria: The analytic hierarchy process applications and progress review,” Journal of Advanced Transportation, 29(1), pp.81-126. Google Scholar ›
38
Senna, P., Reis, A., Santos, I., Dias, A., and Coelho, O. (2020). “A systematic literature review on supply chain risk management: is healthcare management a forsaken research field?,” Benchmarking: An International Journal, 28(3), pp.926-956. Google Scholar ›
39
Senna, P., Reis, A., Marujo, L., Guimarães, J., Severo, E., and Santos, A. (2023). “The influence of supply chain risk management in healthcare supply chains performance,” Production Planning & Control, 35(12), pp.1-16. DOI:10.1080/09537287.2023.2182726. Google Scholar ›
40
Shenoi, V. V., Dath, T. S., and Rajendran, C. (2021). “Supply chain risk management in Indian manufacturing industries: an empirical study and a fuzzy approach,” in Srinivas, S., Rajendran, S., and Ziegler, H. (eds.), Supply Chain Management in Manufacturing and Service Systems: Advanced Analytics for Smarter Decisions, International Series in Operations Research & Management Science, 304, pp.107-145. Google Scholar ›
41
Sugihartanto, M. F., Mahendra, M. R., Baihaqi, I., and Rizaldy, H. (2024). “Supply Chain Risk Management Assessment and Strategy: Case Study in a Hospital Pharmacy,” Jurnal Teknologi dan Manajemen, 22(1), pp.35-44. Google Scholar ›
42
Trkman, P., and McCormack, K. (2009). “Supply chain risk in turbulent environments - a conceptual model for managing supply chain network risk,” International Journal of Production Economics, 119(2), pp.247-258. Google Scholar ›
43
Tri, N. (2024). “The impact of Industry 4.0 adoption barriers on supply chain capacity and operational efficiency: Empirical evidence in Vietnamese transport logistics industry,” Global Business and Finance Review, 29(7), pp.126-139. Google Scholar ›
44
Wang, L., Ren, J., Wang, J., Paraskevadakis, D., and Morecroft, C. (2023). “A comprehensive analysis of diverse risk management strategies in healthcare supply chain,” 7th IEEE International Conference on Transportation Information and Safety, Xi’an, China. Google Scholar ›
45
WHO (2024). “Substandard and falsified medical products,” World Health Organization. https://www.who.int/news-room/fact-sheets/detail/substandard-and-falsified-medical-products. Google Scholar ›
46
Jeong (2024). [참고문헌 자동 생성] Google Scholar ›

AHP 기법을 활용한 헬스케어 공급망 리스크 요인 우선순위 분석